Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: reference to effect on quiescent tumour cells

References

• BROWN, J. M., 1993, SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours. British Journal of Cancer, 67, 1163–1170.
   PubMed Web of Science ®Google Scholar
• BROWN, J. M., and SHm, B. G., 1996, Hypoxia-specific cytotoxins in cancer therapy. Seminars in Radiation Oncology, 6, 22–36.
   PubMed Web of Science ®Google Scholar
• DETHLEFSEN, L. A., 1980, In quest of the quaint quiescent cells. Radiation Biology in Cancer Research, edited by R. E. Meyn and H. R. Withers (New York: Raven Press), pp. 415–435.
   Google Scholar
• DEWEY, W. C., 1994, Arrhenius relationship from the molecule and cell to clinic. International Journal of Hyperthermia, 10, 457–483.
   PubMed Web of Science ®Google Scholar
• FENECH, M., and MORLEY, A. A., 1985, Measurement of micronuclei in lymphocytes. Mutation Research, 147, 29–36.
   PubMed Web of Science ®Google Scholar
• HORSMAN, M. R., CHAPLIN, D. J., and BROWN, J. M., 1989, Tumor radiosensitization by nicotinamide: a result of improved perfusion and oxygenation. Radiation Research, 118, 139–150.
   PubMed Web of Science ®Google Scholar
• JACKSON, R. C., 1989, The problem of the quiescent cancer cell. Advances in Enzyme Regulation, 29, 27–46.
   PubMedGoogle Scholar
• KENNEDY, K. A., TEICHER, B. A., ROCKWELL, S., and SARTORELLI, A. C., 1979, The hypoxic tumor cell: a target for selective cancer chemotherapy. Biochemistry and Pharmacology, 29, 1–8.
   Web of Science ®Google Scholar
• KJELLEN, E., JOINER, M. C., COLLIER, J. M., JOHNS, H., and ROJAS, A. A., 1991, A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fraction-ated X-ray treatments. Radiotherapy and Oncology, 22, 81–91.
   PubMed Web of Science ®Google Scholar
• KocH, C. J., 1993, Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin. Cancer Research, 53, 3992–3997.
   PubMed Web of Science ®Google Scholar
• MASUNAGA, S., ONO, K., and ABE, M., 1992, Potentially lethal damage repair by quiescent cells in murine solid tumors. International Journal of Radiation Oncology Biology Physics, 22, 973–978.
   PubMed Web of Science ®Google Scholar
• MASUNAGA, S., ONO, K., and ABE, M., 1993, The detection and modification of the hypoxic fraction in queiescent cell populations in murine solid tumours. British Journal of Radiology, 66, 918–926.
   PubMed Web of Science ®Google Scholar
• MASUNAGA, S., ONO, K., AKABOSHI, M., KAWAI, K., SUZ UKI, M., KINASHI, Y., and TAKAGAKI, M., 1997a, Augmentation in chemosensitivity of intratumor queiscent cells by combined treatment with nicotinamide and mild hyperthermia. Japanese Journal of Cancer Research, 88, 770–777.
   PubMedGoogle Scholar
• MASUNAGA, S., ONO, K., SUZUKI, M., KINASHI, Y., TAKAGAKI, M., and AKABOSHI, M., 1997b, Alteration in the hypoxic fraction of quiescent cell populations by hyperthermia at mild temperatures. International Journal of Hyperthermia, 13, 401–411.
   PubMed Web of Science ®Google Scholar
• MITCHELL, J., MORSTYN, G., Russo, A., KINSELLA, T., FORNANCE, A., MCPHERSON, S. GLATSTEIN, E., 1984, Differing sensitivity to fluorescent light in Chinese hamster cells containing equally incorporated quantities of BUdR versus IUdR. International Journal of Radiation Oncology Biology Physics, 10, 1447–1451.
   PubMed Web of Science ®Google Scholar
• NISHIMURA, Y., ONO, K., HIRAOKA, M., MASUNAGA, S., JO, S., SHIBAMOTO, Y., SASAI, K., ABE, M., IGA, K., and OGAWA, Y., 1990, Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin. Radiation Research, 122, 161–167.
   PubMed Web of Science ®Google Scholar
• NISHIMURA, Y., SHIBAMOTO, Y., Jo, S., AKUTA, K., HIRAOKA, M., TAKAHASHI, M., and ABE, M., 1988, Relationship between heat-induced vascular damage and thermo-sensitivity in four mouse tumors. Cancer Research, 48, 7226–7230.
   PubMed Web of Science ®Google Scholar
• OLESON, J. R. 1995, Hyperthermia from the clinic to the laboratory: hypothesis (Eugene Robinson Special Lecture). International Journal of Hyperthermia, 11, 315–322.
   PubMed Web of Science ®Google Scholar
• ONO, K., WANDL, E. O., TSUTSUI, K., SASAI, K., and ABE, M., 1989, The correlation between cell survival curve and dose response curve of micronucleus (MN) frequency. Strahlentherapie und Onkologie, 165, 82/I 827.
   Web of Science ®Google Scholar
• OVERGAARD, J., 1989, Sensitization of hypoxic tumor cells—clinical experience. International Journal of Radiation Biology, 56, 801–811.
   PubMed Web of Science ®Google Scholar
• OVERGAARD, J., and HORSMAN, M., 1996, Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Seminars in Radiation Oncology, 6, 10–21.
   PubMed Web of Science ®Google Scholar
• OVERGAARD, J., GONZALES, D. G., HULSHUR, M. C. C. M., ARCHANGELI, G., DAHL, O., MELLA, O., and BENTZEN, S. M., 1995, Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. The Lancet, 345, 540–543.
   PubMed Web of Science ®Google Scholar
• PETERS, C. E., CHAPLIN, D. J., and HIRST, D. G., 1997, Nicotinamide reduces tumour inter-stitial fluid pressure in a dose- and time-dependent manner. British Journal of Radiology, 70, 160–167.
   PubMed Web of Science ®Google Scholar
• SONG, C. W., SHAKIL, A., OSBORN, J. L., and IWATA, K., 1996, Tumour oxygenation is increased by hyperthermia at mild temperatures. International Journal of Hyperthermia, 12, 367–373.
   PubMed Web of Science ®Google Scholar
• VAUPEL, P., 1990, Pathological mechanisms of hyperthermia in cancer therapy. Biological Basis for Oncologic Thermotherapy, edited by M. Gautherie (Heidelberg: Springer-Verlag), pp. 73–134.
   Google Scholar
• WALLEN, C. A., RIDINGER, D. N., and DETHLEFSEN, L. A., 1985, Heterogeneity of X-ray cytotoxicity in proliferating and quiescent murine mammary carcinoma cells. Cancer Research, 45, 3064–3069.
   PubMed Web of Science ®Google Scholar
• WOUTERS, B. G., and BROWN, J. M., 1997, Cells at intermediate oxygen levels can be more important than the 'hypoxic fraction' in determining tumor response to fractionated radiotherapy. Radiation Research, 147, 541–550.
   PubMed Web of Science ®Google Scholar
• ZEMAN, E. M., BROWN, J. M., LEMMON, M. J., HIRST, V. K., and LEE, W. W., 1986, SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. International Journal of Radiation Oncololgy Biology Physics, 12, 1239–1242.
   PubMed Web of Science ®Google Scholar